Events
Event
- Title:
- Biologics and Biosimilars
- When:
- 10/06/2011 12:00 PM - 3:00 PM
- Category:
- Past Events
Description
Biologics and Biosimilars
A Discussion and Educational Opportunity for Physicians,
Advocates and Opinion Leaders!
Biosimilars are biological products that are "highly similar" to or "interchangeable" with innovator biologics. While the U.S. has a new pathway for approving biosimilars under the Public Health Service Act (PHSA), the Food and Drug Administration (FDA) is still developing regulatory guidance. As the FDA moves forward in implementing this pathway, Pennsylvania-and other states-will be tasked with forming science-based, patient-centered law and policy surrounding biosimilar medicines.
Register today for the Biologics and Biosimilars Forum at Harrisburg University of Science and Technology on October 6th!
The purpose of this event is to bring together key Pennsylvania-based stakeholders - patient groups, physicians, opinion leaders and the bioscience community - to facilitate a policy discussion on biosimilars.
Panelists:
Chris. Molineaux, Pennsylvania Bio
Dr. Phil Gerbino, President Emeritus, University of the Sciences
Eric D. Darr, Ph.D., Provost & Executive Vice President, Harrisburg University
Mel Billingsley, Ph.D., President and CEO of the Central Pennsylvania Life Sciences Greenhouse
Kim Greco, Regulatory Affairs Director, Amgen
Lori Davies, Cancer Survivor
Pennsylvania Department of Health
The event is free to attend. Lunch will be served.
For more information on this important event, please contact Annette Eyer @ 717.433.710 or aeyer@cullarigroup.com
Annette Eyer
Alliance and Professional Relations Consultant
Cullari Communications Group
717.433.7109
